Literature DB >> 16778116

Low frequency of BRAF mutations in endometrial and in cervical carcinomas.

Gema Moreno-Bueno, Carolina Sanchez-Estevez, José Palacios, David Hardisson, Tanri Shiozawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16778116     DOI： 10.1158/1078-0432.CCR-06-0284

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  5 in total

1.  Multiplex mutation screening by mass spectrometry evaluation of 820 cases from a personalized cancer medicine registry.

Authors:  Carol Beadling; Michael C Heinrich; Andrea Warrick; Erin M Forbes; Dylan Nelson; Emily Justusson; Judith Levine; Tanaya L Neff; Janice Patterson; Ajia Presnell; Arin McKinley; Laura J Winter; Christie Dewey; Amy Harlow; Oscar Barney; Brian J Druker; Kathryn G Schuff; Christopher L Corless
Journal:  J Mol Diagn       Date:  2011-07-02       Impact factor: 5.568

Review 2.  Endometrial tumour BRAF mutations and MLH1 promoter methylation as predictors of germline mismatch repair gene mutation status: a literature review.

Authors:  Alexander M Metcalf; Amanda B Spurdle
Journal:  Fam Cancer       Date:  2014-03       Impact factor: 2.375

3.  Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance.

Authors:  Robert M W Hofstra; Amanda B Spurdle; Diana Eccles; William D Foulkes; Niels de Wind; Nicoline Hoogerbrugge; Frans B L Hogervorst
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

4.  The genomics and genetics of endometrial cancer.

Authors:  Andrea J O'Hara; Daphne W Bell
Journal:  Adv Genomics Genet       Date:  2012-03

5.  Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI-H) metastatic endometrial cancer.

Authors:  Michele Moschetta; Gabriel Mak; Joana Hauser; Catriona Davies; Mario Uccello; Hendrik-Tobias Arkenau
Journal:  Exp Hematol Oncol       Date:  2017-01-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.